Leadership Team
Pieter Boele
Chairman
Dr. Sasi Suda
CEO
Dr. Pranee Krailadsiri
Chief Medical Officer, General Manager - Thailand
Lesley Werth
VP, Global Clinical Operations
Ming Lim
Global Head of Regulatory Affairs
Dr. Tony Yuan
Medical Writing Manager
Thidarat Maneemoon
Global Quality Assurance Director
Linda Bendall
Principal Medical Writer
Oranuch Nampaisan
Head of Biometrics and Data Management
Pieter Boele
Chairman
Pieter has over 5 decades of chief executive experience, having held numerous directorship and business strategic leadership positions across a variety of global organisations. Pieter has a strong passion for the medical industry and is resolute to providing the right guidance and strategy execution to deliver against the company’s goals.
As Chairman, with Grand Pacific CRO, Pieter is focused on partnering with global pharmaceutical and biotech companies to receive the best possible clinical research support for their clinical trials.
Dr. Sasi Suda
CEO
Sasi Suda is a medical doctor by training. The past twenty-five years has seen Dr Suda working across a multitude of highly regarded roles as a senior clinical research specialist covering diverse areas including but not limited to regulatory affairs, protocol development and compliance, site management, clinical operations, drug safety and pharmacovigilance.
Dr Suda has held key executive and clinical management roles at Alcon Laboratories, Novo Nordisk Pharmaceuticals and Avexa Australia which has contributed to her extensive hands on experience in the management of complex trials and programs through all stages.
Dr Suda is known for her tenacity and passion in this field, she plays a role in every trial and forms positive working relationships with all of our clients. Her dedication to every client and patient is one of the key things that makes working with Grand Pacific CRO different.
Lesley Werth
VP, Global Clinical Operations
Lesley brings over 22 years of clinical research experience to Grand Pacific Pty LTD. As the ANZ General Manager, Lesley is responsible for oversight of all internal functions and ensures the expectations of our external clients are exceeded. She aligns all stakeholders to ensure rapid implementation and execution excellence of Grand Pacific CRO clinical trials.
Lesley has a strong oncology background having trained as a Radiation Therapist. As a clinical research executive, she has held a number of senior leadership positions in clinical operations. She has experience in site management & monitoring, clinical operations, QA, L&D and strategic patient recruitment, retention and advocacy at world leading pharmaceutical companies and clinical research organisations including Abbvie, Abbott, Sanofi, AstraZeneca, Eli Lilly and GreenLight Clinical.
Thidarat Maneemoon
Quality Assurance Director
Thidarat brings over 15 years of Quality Assurance experience to Grand Pacific CRO. As a Global Quality Assurance Director, Thidarat is responsible for driving the quality assurance programs at a global level. Provide direction in support of customer and functional accounts, audit and inspection programs, and quality management systems. Provide insights, analyses, and support in the promotion and assessment of compliance with regulations, guidelines, and operating procedures within the globally assigned.
Thidarat is a pharmacist by education. She has held leadership positions in quality assurance with multinational pharmaceutical companies for a number of years. She has extensive quality assurance experience in both clinical research and marketed products at a global level and a country level. She has been a qualified lead auditor conducting GCP audits including contracted clinical investigator site audits and other GxP audits such as GMP, GDP, GVP and GLP audits for 10 years and hosting client audits, and facilitating a number of regulatory inspections with a satisfactory level of compliance.
Ming Lim
Global Head of Regulatory Affairs
Ming brings over 25 years of experience in Regulatory Affairs management, including strategy development, labelling review and development, dossier authoring/review, regulatory intelligence, CMC technical, regulatory operations, and submissions. As the Global Head of Regulatory Affairs, Ming is responsible for providing regulatory expertise to all GPCRO divisions, securing successful regulatory approvals for our trials and therapeutic products, and developing a highly capable regulatory team. He also assists our clients in managing their regulatory submissions to health authorities including lifecycle management.
Prior to joining Grand Pacific CRO, Ming was the Regulatory Consultant for LEO Pharma and Bayer for Australia and New Zealand markets. He was also the Regional Director for Regulatory CMC Strategy at Pfizer where he led a team of CMC strategists and authors in the Asia Pacific region.
Ming utilises his deep regulatory knowledge and management experience to help advance and make available safe, innovative, and evidence-based medicines to improve people’s quality of life.
Dr. Pranee Krailadsiri
Chief Medical Officer, General Manager - Thailand
Dr. Krailadsiri joined Grand Pacific CRO as a Chief Medical Officer. Equipped with diverse roles and experience in the clinical research industry, from medical affairs, medical information, pharmacovigilance, regulatory affairs, compliance, global, regional and local studies phases I-IV.
After spending more than two decades working in clinical research and pharmaceutical industry, Dr. Krailadsiri identifies what truly makes a successful clinical trial and all the medical activities required for the successful launch of a new product.
With her previous experience as Global Medical Adviser, one of Dr. Krailadsiri’s focuses at GPCRP will be solidifying our global clinical trial capacities, by providing internal training and consolidating functions between departments to ensure the expectations of our external clients are exceeded.
Dr. Krailadsiri is equipped with extensive experiences in medical writing and publication, she has authored and co-authored several manuscripts, abstracts and book chapters. She has also engaged and participated in writing and reviewing many clinical and regulatory documents. These documents address the quality, ethics and timeliness of publications that report clinical trial results.
Not only is Dr. Krailadsiri a Medical Doctor, she also holds a PhD in Haematology from the Addenbrooke’s NHS Trust Open University, UK.
Dr Helen Wu
Global Director, Medical Affairs
Dr Helen Wu is a medical practitioner based in Sydney, Australia with extensive clinical and research experience. She obtained her medical degree from the University of New South Wales and is a Fellow of the Royal Australasian College of Physicians. She specialises in geriatric medicine and currently has clinical appointments in a number of public and private hospitals in Sydney. Her research focus is on Alzheimer’s disease and she has completed a PhD in biomarkers of Alzheimer’s disease from the Centre for Healthy Brain Ageing, UNSW.
She is a clinical lecturer at the University of Sydney and is actively engaged in the training and education of medical students and physician trainees. Dr Wu has been supporting CRO clinical trials for a number of years in the capacity of a medical monitor as well as medical director. At Grand Pacific CRO, Dr Wu is the Global Director for Medical Affairs and oversees medical writing, medical monitoring, and medical safety/pharmacovigilance. Dr Helen Wu is committed to using her clinical and research expertise to advance and provide medical oversight for clinical trials managed by Grand Pacific CRO.
Dr. Tony Yuan
Medical Writing Manager
Tony is an experienced pharmaceutical professional with skills in Medicine Information Optimisation, Regulatory Affairs, Sales, and Marketing from global pharmaceutical companies, including Eli Lilly, GSK, Mylan, Phebra, and Pharmaxis. He has wide-ranging experience in writing and developing product Information/SmPC, consumer medicine information/package leaflet, minimum PI, instruction manual, and labelling to ensure a high level of quality, consistency, and compliance with the local and international regulatory requirements. Tony majors in Medical Microbiology & Immunology and Pharmacology and has a Master’s degree in Drug Development/Pharmaceutical Medicine. Due to his passion for medical writing, he has also pursued a PhD in developing and optimising written medicine information for prescription medicines.
Tony is responsible for providing medical writing expertise and oversight to all medical writing documents for GPCRO, such as manuscript, clinical trial protocol, participant information consent form, investigator’s brochure, pharmacy manual, and clinical study report in alignment with the requirements of GCP and ICH guidance. He utilises his experience and skills to positively impact project deliverables, develop scopes, bring innovation, build excellent relationships with internal and external stakeholders, and provide critical thinking to all aspects of planning and executing.
Oranuch Nampaisan
Head of Biometrics and Data Management
Oranuch is a Biostatistician with 20 years experience in data management and statistical analysis in the public health and clinical research sectors.
At Grand Pacific CRO she is Head of Biometrics and Data Management. Her responsibilities are to drive and supervise the company’s biometrics activities. This includes supervision of all statistical and programming activities as well as data management and analysis.
Linda Bendall
Principal Medical Writer